Kairos Pharma KAPA
NYSE KAPA
$0.55 -0.02 (-3.90%)
As of: Oct 22, 2026 · 10:10 AM EDT

Kairos Pharma (KAPA) Notes Payables (2024)

Updated

Kairos Pharma (KAPA) reported Notes Payables of $792,000 for Q3 2024.

Analysis

Kairos Pharma (KAPA) Notes Payables (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.17 Bn 1,135.76 Bn 19.71 Bn
2 Johnson & Johnson 633.70 Bn 552.23 Bn 17.26 Bn
3 AbbVie 503.94 Bn 477.06 Bn 12.70 Bn
4 Merck 378.10 Bn 332.47 Bn 12.21 Bn
5 Novartis Ag 303.72 Bn 267.71 Bn 11.24 Bn
6 Astrazeneca 266.46 Bn 240.15 Bn 12.86 Bn
7 Amgen 241.07 Bn 196.47 Bn 7.24 Bn
8 Gilead Sciences 194.22 Bn 168.41 Bn 6.22 Bn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn
10 Kairos Pharma 10.21 Mn -2.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 792,000.00
API Access

Kairos Pharma Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=KAPA&period=max&api_key=YOUR_API_KEY